Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19217748rdf:typepubmed:Citationlld:pubmed
pubmed-article:19217748lifeskim:mentionsumls-concept:C0022646lld:lifeskim
pubmed-article:19217748lifeskim:mentionsumls-concept:C0162577lld:lifeskim
pubmed-article:19217748lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:19217748lifeskim:mentionsumls-concept:C0333186lld:lifeskim
pubmed-article:19217748lifeskim:mentionsumls-concept:C0522523lld:lifeskim
pubmed-article:19217748lifeskim:mentionsumls-concept:C2348535lld:lifeskim
pubmed-article:19217748pubmed:issue4lld:pubmed
pubmed-article:19217748pubmed:dateCreated2009-4-3lld:pubmed
pubmed-article:19217748pubmed:abstractTextEndovascular therapy for symptomatic atherosclerotic renal artery stenosis (ARAS) is common but is associated with a significant restenosis rate. This study evaluates the outcomes of percutaneous endoluminal therapy for symptomatic restenosis (>50% on angiography) after renal intervention.lld:pubmed
pubmed-article:19217748pubmed:languageenglld:pubmed
pubmed-article:19217748pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19217748pubmed:citationSubsetIMlld:pubmed
pubmed-article:19217748pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19217748pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19217748pubmed:statusMEDLINElld:pubmed
pubmed-article:19217748pubmed:monthAprlld:pubmed
pubmed-article:19217748pubmed:issn1097-6809lld:pubmed
pubmed-article:19217748pubmed:authorpubmed-author:LumsdenAlan...lld:pubmed
pubmed-article:19217748pubmed:authorpubmed-author:DaviesMark...lld:pubmed
pubmed-article:19217748pubmed:authorpubmed-author:PedenEric KEKlld:pubmed
pubmed-article:19217748pubmed:authorpubmed-author:NaoumJoseph...lld:pubmed
pubmed-article:19217748pubmed:authorpubmed-author:BismuthJean...lld:pubmed
pubmed-article:19217748pubmed:authorpubmed-author:SaadWael AWAlld:pubmed
pubmed-article:19217748pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19217748pubmed:volume49lld:pubmed
pubmed-article:19217748pubmed:ownerNLMlld:pubmed
pubmed-article:19217748pubmed:authorsCompleteYlld:pubmed
pubmed-article:19217748pubmed:pagination946-52lld:pubmed
pubmed-article:19217748pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:19217748pubmed:meshHeadingpubmed-meshheading:19217748...lld:pubmed
pubmed-article:19217748pubmed:meshHeadingpubmed-meshheading:19217748...lld:pubmed
pubmed-article:19217748pubmed:meshHeadingpubmed-meshheading:19217748...lld:pubmed
pubmed-article:19217748pubmed:meshHeadingpubmed-meshheading:19217748...lld:pubmed
pubmed-article:19217748pubmed:meshHeadingpubmed-meshheading:19217748...lld:pubmed
pubmed-article:19217748pubmed:meshHeadingpubmed-meshheading:19217748...lld:pubmed
pubmed-article:19217748pubmed:meshHeadingpubmed-meshheading:19217748...lld:pubmed
pubmed-article:19217748pubmed:meshHeadingpubmed-meshheading:19217748...lld:pubmed
pubmed-article:19217748pubmed:meshHeadingpubmed-meshheading:19217748...lld:pubmed
pubmed-article:19217748pubmed:meshHeadingpubmed-meshheading:19217748...lld:pubmed
pubmed-article:19217748pubmed:meshHeadingpubmed-meshheading:19217748...lld:pubmed
pubmed-article:19217748pubmed:meshHeadingpubmed-meshheading:19217748...lld:pubmed
pubmed-article:19217748pubmed:meshHeadingpubmed-meshheading:19217748...lld:pubmed
pubmed-article:19217748pubmed:meshHeadingpubmed-meshheading:19217748...lld:pubmed
pubmed-article:19217748pubmed:meshHeadingpubmed-meshheading:19217748...lld:pubmed
pubmed-article:19217748pubmed:meshHeadingpubmed-meshheading:19217748...lld:pubmed
pubmed-article:19217748pubmed:meshHeadingpubmed-meshheading:19217748...lld:pubmed
pubmed-article:19217748pubmed:meshHeadingpubmed-meshheading:19217748...lld:pubmed
pubmed-article:19217748pubmed:meshHeadingpubmed-meshheading:19217748...lld:pubmed
pubmed-article:19217748pubmed:meshHeadingpubmed-meshheading:19217748...lld:pubmed
pubmed-article:19217748pubmed:meshHeadingpubmed-meshheading:19217748...lld:pubmed
pubmed-article:19217748pubmed:meshHeadingpubmed-meshheading:19217748...lld:pubmed
pubmed-article:19217748pubmed:meshHeadingpubmed-meshheading:19217748...lld:pubmed
pubmed-article:19217748pubmed:meshHeadingpubmed-meshheading:19217748...lld:pubmed
pubmed-article:19217748pubmed:meshHeadingpubmed-meshheading:19217748...lld:pubmed
pubmed-article:19217748pubmed:meshHeadingpubmed-meshheading:19217748...lld:pubmed
pubmed-article:19217748pubmed:meshHeadingpubmed-meshheading:19217748...lld:pubmed
pubmed-article:19217748pubmed:year2009lld:pubmed
pubmed-article:19217748pubmed:articleTitleOutcomes of endoluminal reintervention for restenosis after percutaneous renal angioplasty and stenting.lld:pubmed
pubmed-article:19217748pubmed:affiliationDepartment of Cardiovascular Surgery, Methodist DeBakey Heart and Vascular Center, The Methodist Hospital, Houston, Tex, USA.lld:pubmed
pubmed-article:19217748pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19217748lld:pubmed